The American Diabetes Association, with Visionary Partners VSP Vision Care and Regeneron, to Address Barriers to Accessing Resources to Manage Ones Eye Health

ARLINGTON, Va., May 2, 2022 /PRNewswire/ — There are currently more than 37 million American adults living with diabetes. Almost three times that many adults (96 million) are living with prediabetes and 90% are completely unaware. Anyone with diabetes is at risk for diabetes-related eye diseases such as diabetic retinopathy, macular edema, glaucoma, and cataracts. … Read more

Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the Association for Research in Vision and Ophthalmology Annual Meeting

VAUGHAN, ON and LAVAL, QC and HEIDELBERG, Germany, May 3, 2022 /PRNewswire/ –– Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, today announced that data from the second pivotal Phase 3 trial … Read more

Bausch + Lomb at ARVO: 13 Poster Presentations NOV03 XIPERE ARMOR

(PRESS RELEASE)VAUGHAN, ONTARIO, AND LAVAL, QUEBEC — Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”), announced the presentation of 13 scientific poster presentations during the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, which will take place in Denver, Colo., from May 1 … Read more

New Research Reveals Significant Gaps in Consumer Contact Lenses Knowledge

New research commissioned by the Contact Lens Institute (CLI) reveals that US eye care practitioners are missing an opportunity to talk about contact lens options with two out of three patients, among other eye-popping findings. The nationwide survey of nearly 1,000 US adults who require vision correction is part of the organization’s See Tomorrow initiative, … Read more

Allergan, an AbbVie Company, to Present New Data from its Leading Portfolio of Eye Care Treatments at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

– Seven abstract presentations showcase ongoing research in presbyopia and glaucoma NORTH CHICAGO, Ill., April 28, 2022 /PRNewswire/ — Allergan, an AbbVie (NYSE: ABBV) company, announced that it will present new data on VUITY™ (pilocarpine HCl ophthalmic solution) 1.25%, the first and only FDA-approved eye drop for the treatment of presbyopia (age-related blurry near vision) … Read more

Bausch + Lomb Will Present New Scientific Data and Analyses on Products and Pipeline Programs During the Association for Research in Vision and Ophthalmology Meeting

13 Poster Presentations Include Results from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane), as well as Data on XIPERE® (Triamcinolone Acetonide Injectable Suspension) for Suprachoroidal Use VAUGHAN, ON and LAVAL, QC, April 28, 2022 /CNW/ — Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) … Read more

MIDO returning April 30th to May 2nd

All set to go at Fiera Milano Rho – MIDO, the leading global eyewear show, returning April 30th to May 2nd. Packed with 650 exhibitors from 45 countries, the event, spread across 5 pavilions, will welcome buyers, opticians and Italian designers and international emotions, it is ready to amaze visitors with the latest innovations and … Read more